Featured News
Press Release
Alzheimer’s Association Welcomes Continued Progress in Alzheimer’s Treatment with FDA Approval of Leqembi Subcutaneous Starter Dose
Chicago, July 13, 2026 — The Alzheimer’s Association welcomes today’s U.S. Food and Drug Administration (FDA) action to approve a subcutaneous starter dose of Leqembi® (lecane...
All News
AIM Blog
A Bit More Suspense as We Enter the Final 24 Hours of the GOP Convention
Each night of the GOP convention has seen suspense on the floor, in one form or another, and Wednesday night...
AIM Blog
Tuesday's Gone
The second day of the 2016 GOP convention was another exciting day in the convention hall as Republicans officially nominated...
AIM Blog
Hello Cleveland!
The 2016 Republican National Convention is officially underway with nearly 50,000 guests, including 15,000 members of the media and 3,000...
AIM Blog
Live from Cleveland
The Alzheimer's Impact Movement (AIM) is proud to bring the issue of Alzheimer's disease to Cleveland this week and Philadelphia...
Press Release
Hope for Alzheimer's Act's Medicare Benefit Proposed at CMS
WASHINGTON, D.C., July 12, 2016 - Today the Alzheimer's Impact Movement (AIM) joined the Alzheimer's Association and advocates across the...
AIM Blog
Alzheimer's Fight Offers Rare Opportunity for Bipartisanship
This was originally published in Morning Consult on June 24, 2016.In a counterpoint to endless talk of Washington partisanship and...